MX341502B - Preparaciones oftálmicas basadas en el factor neurotrófico derivado del cerebro y su uso. - Google Patents
Preparaciones oftálmicas basadas en el factor neurotrófico derivado del cerebro y su uso.Info
- Publication number
- MX341502B MX341502B MX2012005624A MX2012005624A MX341502B MX 341502 B MX341502 B MX 341502B MX 2012005624 A MX2012005624 A MX 2012005624A MX 2012005624 A MX2012005624 A MX 2012005624A MX 341502 B MX341502 B MX 341502B
- Authority
- MX
- Mexico
- Prior art keywords
- bdnf
- brain
- neurotrophic factor
- derived neurotrophic
- ophthalmic preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere a preparaciones oftálmicas en la forma de gotas para ojos basadas en BDNF (Factor Neurotrófico Derivado del Cerebro); las preparaciones pueden ser administradas tópicamente a la superficie del ojo intacta, y son útiles en la prevención y el tratamiento de trastornos neurodegenerativos de la retina, nervio óptico, cuerpo genicular lateral y corteza visual, para evitar la reducción de la capacidad visual y restablecer la función visual normal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A002012A IT1396607B1 (it) | 2009-11-16 | 2009-11-16 | Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso. |
PCT/IB2010/003220 WO2011058449A2 (en) | 2009-11-16 | 2010-11-12 | Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012005624A MX2012005624A (es) | 2012-09-28 |
MX341502B true MX341502B (es) | 2016-08-22 |
Family
ID=42211955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012005624A MX341502B (es) | 2009-11-16 | 2010-11-12 | Preparaciones oftálmicas basadas en el factor neurotrófico derivado del cerebro y su uso. |
Country Status (20)
Country | Link |
---|---|
US (1) | US9387164B2 (es) |
EP (1) | EP2501362B1 (es) |
JP (2) | JP2013510844A (es) |
KR (1) | KR101831793B1 (es) |
CN (2) | CN102639111A (es) |
BR (1) | BR112012011542A2 (es) |
CA (1) | CA2781008C (es) |
CL (1) | CL2012001267A1 (es) |
CY (1) | CY1115853T1 (es) |
DK (1) | DK2501362T3 (es) |
ES (1) | ES2524976T3 (es) |
HR (1) | HRP20141129T1 (es) |
IT (1) | IT1396607B1 (es) |
MX (1) | MX341502B (es) |
PL (1) | PL2501362T3 (es) |
PT (1) | PT2501362E (es) |
RS (1) | RS53687B1 (es) |
RU (1) | RU2564920C2 (es) |
SI (1) | SI2501362T1 (es) |
WO (1) | WO2011058449A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201913468YA (en) * | 2015-07-13 | 2020-03-30 | Tohoku Techno Arch Co Ltd | Composition for optic nerve protection |
ITUA20162343A1 (it) * | 2016-04-06 | 2017-10-06 | Luciano Domenici | Formulazioni intranasali di bdnf per uso nel trattamento di malattie neurodegenerative |
CN111317814B (zh) * | 2020-04-23 | 2020-12-18 | 中国中医科学院眼科医院 | 一种冰片联合神经营养因子组合物及应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1283911B1 (it) * | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
JPH10212241A (ja) | 1996-05-27 | 1998-08-11 | Sumitomo Pharmaceut Co Ltd | Bdnfを安定に含有する製剤 |
CN1233963A (zh) * | 1996-09-13 | 1999-11-03 | 有限会社最先端医学研究所 | 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法 |
IT1305294B1 (it) | 1999-01-29 | 2001-05-04 | Alessandro Lambiase | Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari. |
JP2003048851A (ja) * | 2001-08-03 | 2003-02-21 | Nidek Co Ltd | 視細胞障害疾患治療薬 |
WO2006046584A1 (ja) | 2004-10-26 | 2006-05-04 | Santen Pharmaceutical Co., Ltd. | 視細胞障害治療剤 |
US20070014760A1 (en) * | 2005-07-18 | 2007-01-18 | Peyman Gholam A | Enhanced recovery following ocular surgery |
WO2007101204A1 (en) * | 2006-02-27 | 2007-09-07 | Alcon Research, Ltd. | Method of treating glaucoma |
ITRM20070510A1 (it) * | 2007-10-02 | 2009-04-03 | Rmfa Trading S A | Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico. |
-
2009
- 2009-11-16 IT ITMI2009A002012A patent/IT1396607B1/it active
-
2010
- 2010-11-12 PT PT108090374T patent/PT2501362E/pt unknown
- 2010-11-12 CA CA2781008A patent/CA2781008C/en not_active Expired - Fee Related
- 2010-11-12 US US13/509,824 patent/US9387164B2/en not_active Expired - Fee Related
- 2010-11-12 DK DK10809037.4T patent/DK2501362T3/en active
- 2010-11-12 EP EP10809037.4A patent/EP2501362B1/en active Active
- 2010-11-12 CN CN2010800516551A patent/CN102639111A/zh active Pending
- 2010-11-12 KR KR1020127012512A patent/KR101831793B1/ko active IP Right Grant
- 2010-11-12 WO PCT/IB2010/003220 patent/WO2011058449A2/en active Application Filing
- 2010-11-12 RU RU2012120096/15A patent/RU2564920C2/ru not_active IP Right Cessation
- 2010-11-12 BR BR112012011542A patent/BR112012011542A2/pt not_active IP Right Cessation
- 2010-11-12 SI SI201030793T patent/SI2501362T1/sl unknown
- 2010-11-12 PL PL10809037T patent/PL2501362T3/pl unknown
- 2010-11-12 CN CN201610053193.6A patent/CN105769750A/zh active Pending
- 2010-11-12 JP JP2012538434A patent/JP2013510844A/ja active Pending
- 2010-11-12 MX MX2012005624A patent/MX341502B/es active IP Right Grant
- 2010-11-12 ES ES10809037.4T patent/ES2524976T3/es active Active
- 2010-11-12 RS RS20140644A patent/RS53687B1/en unknown
-
2012
- 2012-05-15 CL CL2012001267A patent/CL2012001267A1/es unknown
-
2014
- 2014-11-20 HR HRP20141129AT patent/HRP20141129T1/hr unknown
- 2014-12-02 CY CY20141101003T patent/CY1115853T1/el unknown
-
2015
- 2015-11-09 JP JP2015219649A patent/JP2016026229A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PL2501362T3 (pl) | 2015-02-27 |
JP2013510844A (ja) | 2013-03-28 |
RU2012120096A (ru) | 2013-11-20 |
US20120258916A1 (en) | 2012-10-11 |
EP2501362A2 (en) | 2012-09-26 |
WO2011058449A2 (en) | 2011-05-19 |
SI2501362T1 (sl) | 2014-12-31 |
CN102639111A (zh) | 2012-08-15 |
KR20120101390A (ko) | 2012-09-13 |
MX2012005624A (es) | 2012-09-28 |
ITMI20092012A1 (it) | 2011-05-17 |
PT2501362E (pt) | 2014-12-04 |
US9387164B2 (en) | 2016-07-12 |
HRP20141129T1 (hr) | 2015-01-02 |
CN105769750A (zh) | 2016-07-20 |
DK2501362T3 (en) | 2014-11-17 |
RS53687B1 (en) | 2015-04-30 |
CY1115853T1 (el) | 2017-01-25 |
ES2524976T3 (es) | 2014-12-16 |
EP2501362B1 (en) | 2014-10-08 |
CA2781008A1 (en) | 2011-05-19 |
KR101831793B1 (ko) | 2018-02-23 |
IT1396607B1 (it) | 2012-12-14 |
BR112012011542A2 (pt) | 2016-06-28 |
RU2564920C2 (ru) | 2015-10-10 |
WO2011058449A3 (en) | 2011-12-01 |
JP2016026229A (ja) | 2016-02-12 |
CA2781008C (en) | 2018-02-06 |
CL2012001267A1 (es) | 2012-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
NZ704247A (en) | Compositions and treatment for eye diseases and disorders | |
MX2009012645A (es) | Formulaciones y metodos para tratar el ojo seco. | |
PH12016500715A1 (en) | Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort | |
WO2011151685A8 (en) | N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament | |
WO2010018996A3 (ko) | 인간 신경줄기세포 및 이를 이용한 중추 또는 말초 신경계 질환 및 손상 치료용 약학적 조성물 | |
ES2571991T3 (es) | Procedimientos para tratar y/o revertir enfermedades y/o trastornos neurodegenerativos | |
MX341502B (es) | Preparaciones oftálmicas basadas en el factor neurotrófico derivado del cerebro y su uso. | |
MX2022005063A (es) | Tratamiento de enfermedades oculares con antagonistas de receptor de endotelina. | |
EP4279063A3 (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
CY1124538T1 (el) | Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης | |
WO2015048188A8 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
PH12020550722A1 (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
WO2012136369A8 (en) | Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma | |
WO2017152129A3 (en) | Treatment of glaucoma and/or retinal diseases and formulations useful therefore | |
WO2014182696A3 (en) | Bioresorbable scaffold for neurologic drug delivery | |
de Alba Campomanes et al. | Myopia associated with optic nerve gliomas in neurofibromatosis type 1 | |
Kiseleva | The role of anthocyanosides in the correction of eye microcirculation and hemodynamic disorders in ophthalmic pathology | |
WO2014003850A3 (en) | Methods for treatment of ocular diseases | |
Ram et al. | Giant Papillae in Vernal Keratoconjunctivitis | |
WO2009007746A3 (en) | Treatment of sensorineural hearing loss | |
MX2009011250A (es) | Promotor de la formacion de neuritas. | |
CN108607003A (zh) | 一种预防及治疗眼部疾病的保健品 | |
MX2022009136A (es) | Composicion farmaceutica oftalmica y uso de la misma. | |
Rode et al. | Bodily representations disorders and sensory manipulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |